Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease

Journal of Proteomics

Volumn 127, Issue , 2015, Pages 386-394

  Ito, Emi ^a   Oka, Ritsuko ^a   Ishii, Takeo ^b   Korekane, Hiroaki ^a   Kurimoto, Ayako ^a   Kizuka, Yasuhiko ^a   Kitazume, Shinobu ^a   Ariki, Shigeru ^c   Takahashi, Motoko ^c   Kuroki, Yoshio ^c   Kida, Kozui ^b   Taniguchi, Naoyuki ^a  

^a RIKEN   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antibody lectin EIA; AQ labeling; Biomarker; COPD; Core fucose; SP D

Indexed keywords

FUCOSE; FUCOSYLATED SURFACTANT PROTEIN D; GLYCAN DERIVATIVE; N GLYCAN; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCULATION; CONTROLLED STUDY; DISEASE SEVERITY; EMPHYSEMA; ENZYME IMMUNOASSAY; FEMALE; FUCOSYLATION; GLYCOBIOLOGY; HUMAN; IMMUNE RESPONSE; LUNG ALVEOLUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SERUM; SMOKING; ANIMAL; BLOOD; CLINICAL TRIAL; GLYCOSYLATION; KNOCKOUT MOUSE; MIDDLE AGED; MOUSE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; BIOMARKERS; FEMALE; FUCOSE; GLYCOSYLATION; HUMANS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 84944158888     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2015.07.011     Document Type: Article

References (51)

1. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., Fukuchi Y., Jenkins C., Rodriguez-Roisin R., van Weel C., Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007, 176:532-555.
2. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., Cherniack R.M., Rogers R.M., Sciurba F.C., Coxson H.O., Pare P.D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004, 350:2645-2653.
3. Murphy T.F. The many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Clin. Infect. Dis. 2008, 47:1534-1536.
4. Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 2008, 359:2355-2365.
5. Angata T., Fujinawa R., Kurimoto A., Nakajima K., Kato M., Takamatsu S., Korekane H., Gao C.-X., Ohtsubo K., Kitazume S., Taniguchi N. Integrated approach toward the discovery of glyco-biomarkers of inflammation-related diseases. Ann. N. Y. Acad. Sci. 2012, 1253:159-169.
6. Fukuchi Y., Nishimura M., Ichinose M., Adachi M., Nagai A., Kuriyama T., Takahashi K., Nishimura K., Ishioka S., Aizawa H., Zaher C. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004, 9:458-465.
7. Lock-Johansson S., Vestbo J., Sorensen G. Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease. Respir. Res. 2014, 15:147-156.
8. Moreno D., Garcia A., Lema D., De Sanctis J.B. Surfactant protein D in chronic obstructive pulmonary disease (COPD). Recent Pat. Endocr., Metab. Immune Drug Discovery 2014, 8:42-47.
9. Persson A., Rust K., Chang D., Moxley M., Longmore W., Crouch E. CP4: a pneumocyte-derived collagenous surfactant-associated protein. Evidence for heterogeneity of collagenous surfactant proteins. Biochemistry 1988, 27:8576-8584.
10. Zhang L., Ikegami M., Crouch E.C., Korfhagen T.R., Whitsett J.A. Activity of pulmonary surfactant protein-D (SP-D) in vivo is dependent on oligomeric structure. J. Biol. Chem. 2001, 276:19214-19219.
11. Lu J., Willis A.C., Reid K.B. Purification, characterization and cDNA cloning of human lung surfactant protein D. Biochem. J. 1992, 284:795-802.
12. Ju C.-R., Liu W., Chen R.-C. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease. Dis. Markers 2012, 32:281-287.
13. Wert S.E., Yoshida M., LeVine A.M., Ikegami M., Jones T., Ross G.F., Fisher J.H., Korfhagen T.R., Whitsett J.A. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5972-5977.
14. Ishii T., Hagiwara K., Kamio K., Ikeda S., Arai T., Mieno M.N., Kumasaka T., Muramatsu M., Sawabe M., Gemma A., Kida K. Involvement of surfactant protein D in emphysema revealed by genetic association study. Eur. J. Hum. Genet. 2012, 20:230-235.
15. Johansson S.L., Tan Q., Holst R., Christiansen L., Hansen N.C.G., Hojland A.T., Wulf-Johansson H., Schlosser A., Titlestad I.L., Vestbo J., Holmskov U., Kyvik K.O., Sorensen G.L. Surfactant protein D is a candidate biomarker for subclinical tobacco smoke-induced lung damage. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 306:L887-L895.
16. Honda Y., Kuroki Y., Matsuura E., Nagae H., Takahashi H., Akino T., Abe S. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am. J. Respir. Crit. Care Med. 1995, 152:1860-1866.
17. Takahashi H., Kuroki Y., Tanaka H., Saito T., Kurokawa K., Chiba H., Sagawa A., Nagae H., Abe S. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am. J. Respir. Crit. Care Med. 2000, 162:258-263.
18. Sin D.D., Leung R., Gan W.Q., Man S.P. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm. Med. 2007, 7:13-19.
19. More J.M., Voelker D.R., Silveira L.J., Edwards M.G., Chan E.D., Bowler R.P. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm. Med. 2010, 10:53-60.
20. Winkler C., Atochina-Vasserman E.N., Holz O., Beers M.F., Erpenbeck V.J., Krug N., Roepcke S., Lauer G., Elmlinger M., Hohlfeld J.M. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir. Res. 2011, 12:29-39.
21. Uozumi N., Yanagidani S., Miyoshi E., Ihara Y., Sakuma T., Gao C.X., Teshima T., Fujii S., Shiba T., Taniguchi N. Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1→6fucosyltransferase. J. Biol. Chem. 1996, 271:27810-27817.
22. Yanagidani S., Uozumi N., Ihara Y., Miyoshi E., Yamaguchi N., Taniguchi N. Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells. J. Biochem. 1997, 121:626-632.
23. Wang X., Inoue S., Gu J., Miyoshi E., Noda K., Li W., Mizuno-Horikawa Y., Nakano M., Asahi M., Takahashi M., Uozumi N., Ihara S., Lee S.H., Ikeda Y., Yamaguchi Y., Aze Y., Tomiyama Y., Fujii J., Suzuki K., Kondo A., Shapiro S.D., Lopez-Otin C., Kuwaki T., Okabe M., Honke K., Taniguchi N. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15791-15796.
24. Gao C., Maeno T., Ota F., Ueno M., Korekane H., Takamatsu S., Shirato K., Matsumoto A., Kobayashi S., Yoshida K., Kitazume S., Ohtsubo K., Betsuyaku T., Taniguchi N. Sensitivity of heterozygous alpha1,6-fucosyltransferase knock-out mice to cigarette smoke-induced emphysema: implication of aberrant transforming growth factor-beta signaling and matrix metalloproteinase gene expression. J. Biol. Chem. 2012, 287:16699-16708.
25. Kamio K., Yoshida T., Gao C., Ishii T., Ota F., Motegi T., Kobayashi S., Fujinawa R., Ohtsubo K., Kitazume S., Angata T., Azuma A., Gemma A., Nishimura M., Betsuyaku T., Kida K., Taniguchi N. alpha1,6-Fucosyltransferase (Fut8) is implicated in vulnerability to elastase-induced emphysema in mice and a possible non-invasive predictive marker for disease progression and exacerbations in chronic obstructive pulmonary disease (COPD). Biochem. Biophys. Res. Commun. 2012, 424:112-117.
26. Yamada M., Ishii T., Ikeda S., Naka-Mieno M., Tanaka N., Arai T., Kumasaka T., Gemma A., Kida K., Muramatsu M., Sawabe M. Association of fucosyltransferase 8 (FUT8) polymorphism Thr267Lys with pulmonary emphysema. J. Hum. Genet. 2011, 56:857-860.
27. Kaneshiro K., Fukuyama Y., Iwamoto S., Sekiya S., Tanaka K. Highly sensitive MALDI analyses of glycans by a new aminoquinoline-labeling method using 3-aminoquinoline/alpha-cyano-4-hydroxycinnamic acid liquid matrix. Anal. Chem. 2011, 83:3663-3667.
28. Global strategy for diagnosis, management, and prevention of COPD Available from. http://www.goldcopd.com/.
29. American Thoracic Society.Standardization of Spirometry Update. American Thoracic Society. Am. J. Respir. Crit. Care Med. 1995, 152:1107-1136.
30. Japanese Respiratory Society The predicted values of spirometry and arterial blood gas analysis in Japanese. J. Jpn. Resp. Soc 2001, 39. (Appendix. Japanese).
31. Nakano Y., Muro S., Sakai H., Hirai T., Chin K., Tsukino M., Nishimura K., Itoh H., Pare P.D., Hogg J.C., Mishima M. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am. J. Respir. Crit. Care Med. 2000, 162:1102-1108.
32. Motohashi N., Kimura K., Ishii T., Wakabayashi R., Kurosaki H., Motegi T., Yamada K., Jones R.C.M., Gemma A., Kida K. Emphysema on imaging is associated with quality of life in elderly patients with chronic obstructive pulmonary disease. Geriatr. Gerontol. Int. 2010, 10:17-24.
33. Korekane H., Hasegawa T., Matsumoto A., Kinoshita N., Miyoshi E., Taniguchi N. Development of an antibody-lectin enzyme immunoassay for fucosylated alpha-fetoprotein. Biochim. Biophys. Acta 1820, 2012:1405-1411.
34. Kurimura Y., Nishitani C., Ariki S., Saito A., Hasegawa Y., Takahashi M., Hashimoto J., Takahashi S., Tsukamoto T., Kuroki Y. Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract. J. Biol. Chem. 2012, 287:39578-39588.
35. Yamazoe M., Nishitani C., Takahashi M., Katoh T., Ariki S., Shimizu T., Mitsuzawa H., Sawada K., Voelker D.R., Takahashi H., Kuroki Y. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J. Biol. Chem. 2008, 283:35878-35888.
36. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:10231-10233.
37. Ohtsubo K., Marth J.D. Glycosylation in cellular mechanisms of health and disease. Cell 2006, 126:855-867.
38. Nagae H., Takahashi H., Kuroki Y., Honda Y., Nagata A., Ogasawara Y., Abe S., Akino T. Enzyme-linked immunosorbent assay using F(ab')2 fragment for the detection of human pulmonary surfactant protein D in sera. Clin. Chim. Acta 1997, 266:157-171.
39. Taniguchi N., Korekane H. Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics. BMB Rep. 2011, 44:772-781.
40. Zhao Y., Sato Y., Isaji T., Fukuda T., Matsumoto A., Miyoshi E., Gu J., Taniguchi N. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 2008, 275:1939-1948.
41. Kurimoto A., Kitazume S., Kizuka Y., Nakajima K., Oka R., Fujinawa R., Korekane H., Yamaguchi Y., Wada Y., Taniguchi N. The absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function. J. Biol. Chem. 2014, 289:11704-11714.
42. Vanhooren V., Dewaele S., Kuro-O M., Taniguchi N., Dolle L., van Grunsven L.A., Makrantonaki E., Zouboulis C.C., Chen C.C., Libert C. Alteration in N-glycomics during mouse aging: a role for FUT8. Aging Cell 2011, 10:1056-1066.
43. Knezevic A., Gornik O., Polasek O., Pucic M., Redzic I., Novokmet M., Rudd P.M., Wright A.F., Campbell H., Rudan I., Lauc G. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 2010, 20:959-969.
44. Scanlin T.F., Wang Y.M., Glick M.C. Altered fucosylation of membrane glycoproteins from cystic fibrosis fibroblasts. Pediatr. Res. 1985, 19:368-374.
45. Wang Y.M., Hare T.R., Won B., Stowell C.P., Scanlin T.F., Glick M.C., Hard K., van Kuik J.A., Vliegenthart J.F. Additional fucosyl residues on membrane glycoproteins but not a secreted glycoprotein from cystic fibrosis fibroblasts. Clin. Chim. Acta 1990, 188:193-210.
46. Hu P., Shi B., Geng F., Zhang C., Wu W., Wu X.Z. E-cadherin core fucosylation regulates nuclear beta-catenin accumulation in lung cancer cells. Glycoconj. J. 2008, 25:843-850.
47. Rhim A.D., Stoykova L., Glick M.C., Scanlin T.F. Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell. Glycoconj. J. 2001, 18:649-659.
48. Tsai H.-Y., Boonyapranai K., Sriyam S., Yu C.-J., Wu S.-W., Khoo K.-H., Phutrakul S., Chen S.-T. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer. Proteomics 2011, 11:2162-2170.
49. Matsumura K., Higashida K., Ishida H., Hata Y., Yamamoto K., Shigeta M., Mizuno-Horikawa Y., Wang X., Miyoshi E., Gu J., Taniguchi N. Carbohydrate binding specificity of a fucose-specific lectin from Aspergillus oryzae: a novel probe for core fucose. J. Biol. Chem. 2007, 282:15700-15708.
50. Domon B., Costello C.E. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj. J. 1988, 5:398-409.
51. Ito E, Oka R, Ishii T, Korekane H, Krimoto A, Kizuka Y, Kitazume S, Ariki S, Takahashi M, Kuroki Y, Kida K, Taniguchi N. Supporting data on this article entitled "Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease" Data in Brief item.